Pymepharco Joint Stock Company

Similar suppliers you may like

Supplier logo

Pharbaco Central Pharmaceutical Joint Stock Company I

🇻🇳 Vietnam
1954
501-1000 people
Manufacturer/Trading Company/Distributor
High capacity factory
Established brand
OEM manufacturer
High-tech enterprise
Shipments
24
Key customer
SUN JEU PHARMA
Key market
Europe
Description
Pharbaco Central Pharmaceutical Joint Stock Company I is a premier pharmaceutical manufacturer and distributor based in Hanoi, Vietnam. Established in 1954, the company has a 70-year history as a cornerstone of the national pharmaceutical industry. Operating as a manufacturer, trading company, and OEM/contract manufacturer, Pharbaco maintains a workforce of 501 to 1,000 employees and manages a significant production complex in Soc Son District. The company is recognized for its extensive manufacturing capabilities, featuring modern production lines from Germany, the UK, and the US, and holds certifications including WHO-GMP, EU-GMP, GLP, and GSP. Pharbaco offers a diverse portfolio of over 500 products across various therapeutic categories, including antibiotics (Cephalosporin, Penicillin, and Carbapenem), cardiovascular medications, anti-inflammatory drugs, vitamins, and dietary supplements. Their production facilities include specialized lines for injectable powders, oral solid dosages (OSD), and traditional medicinal herbs. Beyond pharmaceuticals, the company is involved in the supply of medical equipment, cosmetics, and specialized drugs for national health programs targeting tuberculosis and malaria. With a strong focus on research and development, Pharbaco operates international-standard laboratories and R&D centers in Hanoi and Ho Chi Minh City. The company has a robust international trade presence, exporting high-quality Vietnamese medicines to over 20 countries and territories worldwide. Listed on the UPCOM market under the ticker PBC, Pharbaco continues to expand its scale through multi-phase factory upgrades to meet evolving global healthcare standards.
Fabafixim
Fabafixim
Cefadroxil 250mg
Cefadroxil 250mg
Introduce | Pharbaco
Introduce | Pharbaco
Pharbaco factory
Pharbaco factory
Pharbaco Building
Pharbaco Building
Pharbaco Central Pharmaceutical Joint Stock Company
Pharbaco Central Pharmaceutical Joint Stock Company
Supplier logo

Mekophar Chemical Pharmaceutical Joint-Stock Company

🇻🇳 Vietnam
1975
501-1000 people
Manufacturer/Trading Company/Distributor
High capacity factory
Established brand
Own brand
Industry association member
Shipments
17
Key customer
NIPRO
Key market
🇻🇳 Vietnam
Description
Mekophar Chemical Pharmaceutical Joint-Stock Company (MEKOPHAR) is a prominent Vietnamese pharmaceutical manufacturer and distributor headquartered in Ho Chi Minh City. Established in 1975 and equitized as a joint-stock company in 2002, the organization has grown into a major industry player with a workforce of approximately 500 to 1,000 employees and an annual revenue estimated at $157.9 million. The company operates multiple production bases and a nationwide distribution network with branches in Hanoi, Da Nang, and Can Tho. Mekophar specializes in a comprehensive range of healthcare solutions, including the manufacturing, export, and import of pharmaceuticals, herbal medicines, and oriental medicines. Its extensive product portfolio covers therapeutic areas such as antibiotics (oral and injectable), analgesics, antipyretics, cardiovascular drugs, gastrointestinal agents, and antimalarials. Beyond finished dosage forms, the company supplies pharmaceutical raw materials, medical devices, and specialized packaging solutions including plastic bottles and carton boxes. As a vertically integrated manufacturer, Mekophar offers OEM services and maintains a focus on high-quality standards to serve both domestic and international markets. The company has also diversified its business interests into stem cell banking services through its relationship with Mekostem, as well as food technology and cosmetics. Listed on the UPCOM securities trading center under the ticker MKP, Mekophar remains a key contributor to the regional pharmaceutical sector through its commitment to safe and effective public health products.
Mekophar company building
Mekophar company building
Mekophar Logo
Mekophar Logo
Mekophar Building
Mekophar Building
pharmaceuticals
pharmaceuticals

Explore supplier list

Turn your product ideas into reality today

Get started for free